Successful management of SARS-CoV-2 acute respiratory distress syndrome and newly diagnosed acute lymphoblastic leukemia

Standard chemotherapy can still be used for new diagnosis of acute lymphoblastic leukemia in patients with SARS-CoV-2. Corticosteroid can be given safely to patients with SARS-CoV-2 presenting with acute respiratory distress syndrome and ALL.

Detalles Bibliográficos
Autores principales: Phillips, Lia, Pavisic, Jovana, Kaur, Dominder, Dorrello, N. Valerio, Broglie, Larisa, Hijiya, Nobuko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2020
Materias:
Exceptional Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509888/
https://www.ncbi.nlm.nih.gov/pubmed/32926122
http://dx.doi.org/10.1182/bloodadvances.2020002745

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509888/
https://www.ncbi.nlm.nih.gov/pubmed/32926122
http://dx.doi.org/10.1182/bloodadvances.2020002745

Ejemplares similares